Biotechnology
Moderna Adjusts 2025 Revenue Forecast Due to UK Vaccine Shipment Delays: What It Means for Investors
Moderna recently adjusted its revenue forecast for 2025, lowering expectations due to delays in vaccine shipments to the U.K. Even ... Read more
Breaking News: Vinay Prasad Leaves the FDA—What This Means for Public Health
Vinay Prasad, a key figure at the Food and Drug Administration (FDA), recently left his position amidst some heated discussions ... Read more
UnitedHealth Predicts Lower 2025 Earnings Amid Rising Medical Costs: What It Means for Insurers
UnitedHealth Group recently shared its outlook for 2025, and the news isn’t great. The company anticipates adjusted earnings of at ... Read more
FDA Resumes Approval of Sarepta Therapeutics’ Duchenne Therapy for Younger Patients: What You Need to Know
The FDA has made a significant announcement regarding Sarepta Therapeutics’ gene therapy for Duchenne muscular dystrophy. Effective Monday, the agency ... Read more
UnitedHealth Collaborates with DOJ on Medicare Billing Practices Investigation: What You Need to Know
UnitedHealth Group is currently under investigation by the Justice Department regarding its Medicare billing practices. This comes as a significant ... Read more
Sarepta Therapeutics’ Duchenne Therapy: What an FDA Official Says About Its Challenging Road to Market
Sarepta Therapeutics is facing tough challenges with its gene therapy for Duchenne muscular dystrophy, called Elevidys. This treatment is currently ... Read more
Breaking News: Sarepta Therapeutics Suspends Duchenne Gene Therapy Shipments—What This Means for Patients
Sarepta Therapeutics announced it will stop shipments of Elevidys, a gene therapy for Duchenne muscular dystrophy, following a request from ... Read more
Sarepta Therapeutics Cuts One-Third of Workforce: What This Means for the Future of the Company
Sarepta Therapeutics has recently made significant cutbacks, laying off about 500 employees, which is more than one-third of its workforce. ... Read more
Trump’s Bold Move: Upcoming 200% Tariff on Pharmaceuticals Could Impact Your Wallet!
President Donald Trump has recently announced plans to impose tariffs of up to 200% on pharmaceuticals imported into the U.S. ... Read more
Exciting Breakthrough: Moderna’s Flu Vaccine Shines in Late-Stage Trials, Setting the Stage for a Combined COVID Vaccine
Moderna recently revealed that its new mRNA-based flu vaccine is showing promise. In late-stage trials, it triggered a stronger immune ... Read more
